Prognostic impact of prior cardiopathy in patients hospitalized with COVID-19 pneumonia

Isabel Monedero-Sánchez, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Pablo Robles-Velasco, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Elia Pérez-Fernández, Unidad de Investigación. Hospital Universitario Fundación Alcorcón, Madrid, España
Amador Rubio-Caballero, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Cecilia Marco-Quirós, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Victoria Espejo-Bares, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Verónica Artiaga-de-la-Barrera, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Carla Jiménez-Martínez, Servicio de Cirugía de Tórax y Cardiovascular, Hospital Civil Fray Antonio Alcalde, Guadalajara, Jal., México
Carlos García-Jiménez, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España
Pablo González-Alirangues, Unidad de Cardiología, Hospital Universitario Fundación Alcorcón, Madrid, España

Background and Objective: From the onset of COVID-19 pandemic, the presence of previous cardiopathy was thought to be related with a worse prognosis of the disease. We aimed to analyse that theoretical adverse impact in a large cohort of patients. Method: We selected 1065 patients admitted for SARS-CoV-2 pneumonia between March and June 2020, divided in three groups according to (1) absence of cardiopathy, (2) presence of valvular heart disease or ischemic heart disease, or (3) presence of heart failure. We analysed the differences between groups regarding the need for admission in intensive care unit for mechanical ventilation or mortality during admission, or mortality during admission or in the next 6 months. Results: The factors that were associated with a worse prognosis both in acute phase and in the next 6 months were age, male gender, obesity and oncologic disease. The presence of previous cardiopathy did not have an adverse prognostic impact neither initially nor in the short term, in our study. Conclusions: We did not obtain significative association of the presence of cardiopathy with a worse medical evolution, neither in acute phase nor in the short term, of patients admitted for SARS-CoV-2 pneumonia.

Keywords: COVID-19. Cardiopathy. Heart failure. Prognosis. Mortality.